Heavy menstrual bleeding treatment patterns and associated health care utilization and costs

Journal of Clinical Outcomes Management

Volumn 19, Issue 9, 2012, Pages 402-413

  Copher, Ronda ^c   Le Nestour, Elisabeth ^a   Zampaglione, Edio ^b   Prezioso, Alexander N ^b   Pocoski, Jennifer ^b   Law, Amy W ^b  

^a PharmaNet/i3   (France)

^b BAYER CORPORATION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; COST OF ILLNESS; DRUG MEGADOSE; ENDOMETRIUM ABLATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEAVY MENSTRUAL BLEEDING; HUMAN; HYSTERECTOMY; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MYOMECTOMY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UTERINE ARTERY EMBOLIZATION;

EID: 84866280528     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reporductive age. Int J Gynaecol Obstet 2011;113:3-13.
2. Kadir RA, Edlund M, Von Mackensen S. The impact of menstrual disorders on quality of life in women with inherited bleeding disorders. Haemophilia 2010;16:932-9.
3. Byams VR. Women with bleeding disorders. J Womens Health (Larchmt) 2007;16:1249-51. (Pubitemid 350125872)
4. Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004;190:1216-23. (Pubitemid 38692200)
5. Lukes AS, Muse K, Richter HE, et al. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding. Curr Med Res Opin 2010;26:2673-8.
6. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2006:CD003855.
7. Liu Z, Doan QV, Blumenthal P, et al. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10:183-94. (Pubitemid 46802276)
8. Hurskainen R, Grenman S, Komi I, et al. Diagnosis and treatment of menorrhagia. Acta Obstet Gynecol Scand 2007;86:749-57. (Pubitemid 46801790)
9. Speroff L, Fritz MA, eds. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
10. Lethaby A, Irvine GA, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008:CD001016.
11. Marret H, Fauconnier A, Chabbert-Buffet N, et al. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010;152:133-7.
12. Fraser IS, Healy DL, Torode H, et al. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia. Obstet Gynecol 1996;87:544-50. (Pubitemid 26102739)
13. Narayan A, Lee AS, Kuo G, et al. Uterine artery embolization vs. abdominal myomectomy: a long-term clinical outcome comparison. J Vasc Interv Radiol 2010;21:1011-7.
14. Lethaby A, Hickey M, Garry R, et al. Endometrial resection/ ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2009:CD001501.
15. Côté I, Jacobs P, Cumming DC. Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 2002;100:683-7. (Pubitemid 35300023)
16. Health Insurance Portability and Accountability Act of 1996. In: 104th Congress and US Department of Health and Human Services, ed., Public law 104-191. Available at: www.cms.hhs.gov/HIPAAGenInfo/Downloads/ HIPAALaw.pdf.
17. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83. (Pubitemid 17055592)
18. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD- 10 administrative data. Med Care 2005;43:1130-9. (Pubitemid 41587600)
19. Copher R, LeNestour E, Presioso A, et al. Variation in treatment of heavy menstrual bleeding by age and underlying cause. Submitted.
20. You JH, Sahota DS, MoYuen P. A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia. Hum Reprod 2006;21:1878-83. (Pubitemid 44028264)
21. Showstack J, Lin F, Learman LA, et al. Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: resource use in the Medicine or Surgery (Ms) trial. Am J Obstet Gynecol 2006;194:332-8. (Pubitemid 43183680)
22. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-63. (Pubitemid 38543736)
23. Fernandez H, Kobelt G, Gervaise A. Economic evaluation of three surgical interventions for menorrhagia. Hum Reprod 2003;18:583-7. (Pubitemid 36329329)
24. Kilonzo MM, Sambrook AM, Cook JA, et al. A cost-utility analysis of microwave endometrial ablation versus thermal balloon endometrial ablation. Value Health 2010;13:528-34.
25. Clegg JP, Guest JF, Hurskainen R. Cost-utility of levo norgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Curr Med Res Opin 2007;23:1637-48. (Pubitemid 47122173)
26. Brown PM, Farquhar CM, Lethaby A, et al. Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006;113:797-803. (Pubitemid 43961741)
27. Harlow SD, Campbell OMR. Epidemiology of menstrual disorders in developing countries: a systematic review. BJOG 2004;111:6-16. (Pubitemid 38223326)
28. Critchley HO, Warner PE, Lee AJ, et al. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess 2004;8: iii-iv, 1-139.
29. Telner DE, Jakubovicz D. Approach to diagnosis and management of abnormal uterine bleeding. Can Fam Physician 2007;53:58-64. (Pubitemid 46166587)
30. Morrison J, Patel ST, Watson W, et al. Assessment of the prevalence and impact of anemia on women hospitalized for gynecologic conditions associated with heavy uterine bleeding. J Reprod Med 2008;53:323-30. (Pubitemid 351846376)